Lymphoma, Large Cell
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT01118845) | SymBio Pharmaceuticals | 2010-04-01 |
| Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL (NCT00546793) | Gilead Sciences | 2008-01-01 |
| MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma (NCT00298467) | Bristol-Myers Squibb | 2006-02-01 |
| Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT (NCT00256490) | Eric Turcotte | 2005-11-01 |
| Large Cell Lymphoma Pilot Study III (NCT00187070) | St. Jude Children's Research Hospital | 1997-12-01 |
| A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies (NCT00051597) | Seagen Inc. |
Track Lymphoma, Large Cell automatically
Every clearance here is in the API, with alerts when new ones post.